Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies

• Clare A. BalendranAstraZeneca (Sweden)
• Ann LövgrenAstraZeneca (Sweden)
• Kenny M. HanssonAstraZeneca (Sweden)
• Karin NelanderAstraZeneca (Sweden)
• Marita OlssonAstraZeneca (Sweden)
• Karin J. JohanssonAstraZeneca (Sweden)
• Karim BrohiQueen Mary University of London
• Dietmar R. FriesInnsbruck Medical University
• Anders BerggrenAstraZeneca (Sweden)